Clinical Trial Update: Signature Development and Validation Protocol for an Epigenetic Assay in Diagnosing Pancreatic Cancer

View source ↗

Summary

A trial update describing the development and validation plan for an epigenetic assay intended to diagnose pancreatic cancer; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Pancreatic Cancer, Advanced or Metastatic | Status: NOT_YET_RECRUITING